Literature DB >> 16137567

Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat.

Ronald L Klein1, Robert D Dayton, Wen-Lang Lin, Dennis W Dickson.   

Abstract

Using a viral vector for mutant (P301L) tau, we studied the effects of gene transfer to the rat substantia nigra in terms of structural and functional properties of dopaminergic neurons. The mutant tau vector caused progressive loss of pars compacta dopaminergic neurons over time, reduced striatal dopamine content, and amphetamine-stimulated rotational behavior consistent with a specific lesion effect. In addition, structural studies demonstrated neurofibrillary tangles and neuritic pathology. Wild-type tau had similar effects on neuronal loss and rotational behavior. In contrast, mutant alpha-synuclein vectors did not induce rotational behavior, although alpha-synuclein filaments formed in nigrostriatal axons. Dopamine neuron function is affected by tau gene transfer and appears to be more susceptible to tau- rather than alpha-synuclein-related damage in this model. Both tau and alpha-synuclein are important for substantia nigra neurodegeneration models in rats, further indicating their potential as therapeutic targets for human diseases involving loss of dopamine neurons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137567      PMCID: PMC2975329          DOI: 10.1016/j.nbd.2005.02.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  47 in total

1.  Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.

Authors:  D W Dickson; H Ksiezak-Reding; W K Liu; P Davies; A Crowe; S H Yen
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments.

Authors:  A Crowe; H Ksiezak-Reding; W K Liu; D W Dickson; S H Yen
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

3.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

4.  Tau pathology in a family with dementia and a P301L mutation in tau.

Authors:  S S Mirra; J R Murrell; M Gearing; M G Spillantini; M Goedert; R A Crowther; A I Levey; R Jones; J Green; J M Shoffner; B H Wainer; M L Schmidt; J Q Trojanowski; B Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  1999-04       Impact factor: 3.685

5.  Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.

Authors:  L A Sternberger; N H Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Tau and ubiquitin immunoreactivity at different stages of formation of Alzheimer neurofibrillary tangles.

Authors:  C Bancher; C Brunner; H Lassmann; H Budka; K Jellinger; F Seitelberger; I Grundke-Iqbal; K Iqbal; H M Wisniewski
Journal:  Prog Clin Biol Res       Date:  1989

7.  Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations.

Authors:  K Wakabayashi; K Oyanagi; T Makifuchi; F Ikuta; A Homma; Y Homma; Y Horikawa; S Tokiguchi
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.

Authors:  Marie-Christine Chartier-Harlin; Jennifer Kachergus; Christophe Roumier; Vincent Mouroux; Xavier Douay; Sarah Lincoln; Clotilde Levecque; Lydie Larvor; Joris Andrieux; Mary Hulihan; Nawal Waucquier; Luc Defebvre; Philippe Amouyel; Matthew Farrer; Alain Destée
Journal:  Lancet       Date:  2004 Sep 25-Oct 1       Impact factor: 79.321

Review 9.  Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy.

Authors:  J Götz; J R Streffer; D David; A Schild; F Hoerndli; L Pennanen; P Kurosinski; F Chen
Journal:  Mol Psychiatry       Date:  2004-07       Impact factor: 15.992

10.  Monoclonal antibodies to Alzheimer neurofibrillary tangles. 1. Identification of polypeptides.

Authors:  S H Yen; A Crowe; D W Dickson
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

View more
  21 in total

1.  Transcriptome analysis of a tau overexpression model in rats implicates an early pro-inflammatory response.

Authors:  David B Wang; Robert D Dayton; Richard M Zweig; Ronald L Klein
Journal:  Exp Neurol       Date:  2010-03-24       Impact factor: 5.330

2.  Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins.

Authors:  Ronald L Klein; Robert D Dayton; Nancy J Leidenheimer; Karen Jansen; Todd E Golde; Richard M Zweig
Journal:  Mol Ther       Date:  2005-12-01       Impact factor: 11.454

Review 3.  Versatile somatic gene transfer for modeling neurodegenerative diseases.

Authors:  Ronald L Klein; David B Wang; Michael A King
Journal:  Neurotox Res       Date:  2009-08-11       Impact factor: 3.911

4.  A Preliminary Study on Investigation of Serum α-Synuclein and Tau Protein Levels in Children with Attention Deficit Hyperactivity Disorder.

Authors:  Ihsan Cetin; Seref Simsek
Journal:  Indian J Clin Biochem       Date:  2016-08-03

5.  Cre-inducible Adeno Associated Virus-mediated Expression of P301L Mutant Tau Causes Motor Deficits and Neuronal Degeneration in the Substantia Nigra.

Authors:  Yang You; Mina B Botros; Alicia A Van Enoo; Aaron Bockmiller; Shawn Herron; Jean Christophe Delpech; Tsuneya Ikezu
Journal:  Neuroscience       Date:  2019-11-02       Impact factor: 3.590

6.  Parkin attenuates wild-type tau modification in the presence of beta-amyloid and alpha-synuclein.

Authors:  Charbel E-H Moussa
Journal:  J Mol Neurosci       Date:  2008-06-17       Impact factor: 3.444

7.  Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states.

Authors:  Ronald L Klein; Robert D Dayton; Jason B Tatom; Cynthia G Diaczynsky; Michael F Salvatore
Journal:  Eur J Neurosci       Date:  2008-04       Impact factor: 3.386

8.  Gene Therapy Models of Alzheimer's Disease and Other Dementias.

Authors:  Benjamin Combs; Andrew Kneynsberg; Nicholas M Kanaan
Journal:  Methods Mol Biol       Date:  2016

9.  AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method.

Authors:  Ronald L Klein; Robert D Dayton; Jason B Tatom; Karen M Henderson; Phillip P Henning
Journal:  Mol Ther       Date:  2007-10-23       Impact factor: 11.454

10.  Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression.

Authors:  Jason B Tatom; David B Wang; Robert D Dayton; Omar Skalli; Michael L Hutton; Dennis W Dickson; Ronald L Klein
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.